SECURITIES SUBSCRIPTION AGREEMENTSecurities Subscription Agreement • August 8th, 2023 • Novavax Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 8th, 2023 Company Industry JurisdictionThis SECURITIES SUBSCRIPTION AGREEMENT (this “Agreement”) is made and entered into this 8th day of August, 2023 (“Effective Date”) by and among Novavax, Inc., a Delaware corporation having a place of business at 21 Firstfield Rd., Gaithersburg, MD 20878 (the “Company”), and SK bioscience Co., Ltd., a company incorporated in the Republic of Korea having a place of business at 310 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do 13494, Republic of Korea (“SK”). The Company and SK shall each be hereinafter referred to as a “Party” and collectively as the “Parties”.